Sandra Martínez-Martín

510 total citations
6 papers, 57 citations indexed

About

Sandra Martínez-Martín is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Sandra Martínez-Martín has authored 6 papers receiving a total of 57 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 2 papers in Oncology and 2 papers in Hematology. Recurrent topics in Sandra Martínez-Martín's work include Protein Degradation and Inhibitors (4 papers), Multiple Myeloma Research and Treatments (2 papers) and Ubiquitin and proteasome pathways (2 papers). Sandra Martínez-Martín is often cited by papers focused on Protein Degradation and Inhibitors (4 papers), Multiple Myeloma Research and Treatments (2 papers) and Ubiquitin and proteasome pathways (2 papers). Sandra Martínez-Martín collaborates with scholars based in Spain, Palestinian Territory and Italy. Sandra Martínez-Martín's co-authors include Laura Soucek, Marie-Ève Beaulieu, Daniel Massó-Vallés, Toni Jauset, Jonathan R. Whitfield, Laia Foradada, Stephan Siegel, Sílvia Casacuberta‐Serra, Jun Yokota and Mariano F. Zacarías Fluck and has published in prestigious journals such as Genes & Development, Oncotarget and Cancers.

In The Last Decade

Sandra Martínez-Martín

6 papers receiving 57 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sandra Martínez-Martín Spain 6 48 24 12 8 5 6 57
Idoia García‐Ramírez Spain 4 25 0.5× 10 0.4× 13 1.1× 7 0.9× 7 1.4× 6 41
Cyrus Y. Jin United States 5 110 2.3× 21 0.9× 5 0.4× 6 0.8× 7 1.4× 8 120
Olga Alexandra Sidorova Germany 3 39 0.8× 26 1.1× 5 0.4× 11 1.4× 2 0.4× 4 55
Susanne Kratzat Germany 3 38 0.8× 27 1.1× 10 0.8× 4 0.5× 4 0.8× 3 50
Taylor Chen United States 2 27 0.6× 12 0.5× 10 0.8× 7 0.9× 7 1.4× 3 42
Marie-Christine Weller Switzerland 3 37 0.8× 27 1.1× 4 0.3× 8 1.0× 9 1.8× 3 53
Jamie Moon United States 4 46 1.0× 10 0.4× 8 0.7× 15 1.9× 6 1.2× 8 69
Dana Gaffney United States 5 70 1.5× 15 0.6× 4 0.3× 10 1.3× 3 0.6× 9 84
Camille Montersino France 4 28 0.6× 9 0.4× 21 1.8× 6 0.8× 7 1.4× 5 39
Yi Bei China 4 61 1.3× 7 0.3× 8 0.7× 15 1.9× 3 0.6× 7 76

Countries citing papers authored by Sandra Martínez-Martín

Since Specialization
Citations

This map shows the geographic impact of Sandra Martínez-Martín's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Martínez-Martín with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Martínez-Martín more than expected).

Fields of papers citing papers by Sandra Martínez-Martín

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra Martínez-Martín. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Martínez-Martín. The network helps show where Sandra Martínez-Martín may publish in the future.

Co-authorship network of co-authors of Sandra Martínez-Martín

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra Martínez-Martín. A scholar is included among the top collaborators of Sandra Martínez-Martín based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra Martínez-Martín. Sandra Martínez-Martín is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Fluck, Mariano F. Zacarías, Daniel Massó-Vallés, Sílvia Casacuberta‐Serra, et al.. (2023). Reducing MYC's transcriptional footprint unveils a good prognostic gene signature in melanoma. Genes & Development. 37(7-8). 303–320. 5 indexed citations
2.
Martínez-Martín, Sandra, Marie-Ève Beaulieu, & Laura Soucek. (2023). Targeting MYC-driven lymphoma: lessons learned and future directions. Cancer Drug Resistance. 6(2). 205–222. 8 indexed citations
3.
Beaulieu, Marie-Ève, et al.. (2023). Pharmacokinetic Analysis of Omomyc Shows Lasting Structural Integrity and Long Terminal Half-Life in Tumor Tissue. Cancers. 15(3). 826–826. 10 indexed citations
4.
Fluck, Mariano F. Zacarías, Toni Jauset, Sandra Martínez-Martín, et al.. (2021). The Wnt signaling receptor Fzd9 is essential for Myc-driven tumorigenesis in pancreatic islets. Life Science Alliance. 4(5). e201900490–e201900490. 7 indexed citations
5.
Martínez-Martín, Sandra & Laura Soucek. (2021). MYC inhibitors in multiple myeloma. Cancer Drug Resistance. 4(4). 842–865. 15 indexed citations
6.
Jauset, Toni, Daniel Massó-Vallés, Sandra Martínez-Martín, et al.. (2018). BET inhibition is an effective approach against KRAS-driven PDAC and NSCLC. Oncotarget. 9(27). 18734–18746. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026